Global Ablation Technology Market Overview:
Ablation is an established treatment strategy for a number of different cardiac arrhythmias. In the past decade, two main areas of expansion have been atrial fibrillation (AF) and ventricular tachycardia (VT) ablation associated with structurally abnormal hearts. It can treat atrial fibrillation. When combined with a full treatment program, catheter ablation can improve your quality of life and eliminate or reduce the uncomfortable symptoms of atrial fibrillation such as shortness of breath, tiredness, or weakness. In parallel to the growing role of catheter ablation for AF and VT, several new technologies have been developed that are intended to increase the safety and the success of the procedure. Areas of development include novel catheter designs, novel navigation technologies, and higher resolution imaging techniques. The aim of this review is to provide an overview of novel developments in AF ablation and VT ablation in patients with structural heart disease.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Forecast Period | 2023-2028 |
Historical Period | 2018-2022 |
Unit | Value (USD Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Influencing Trend:
Increasing Number of Hospitals, Surgical, And Ablation Centers and The Use of Ablation Technology for the Treatment of Cancer
Market Growth Drivers:
Rising Incidence of Atrial Fibrillation across the Globe, Increasing Number of Ablation Procedures, The Large Population Base and The Rising Prevalence of Cancer
Challenges:
The Availability of Various Radiation Devices
Restraints:
High Per-Unit Cost Of These Devices and Limited Reimbursement
Opportunities:
High Prevalence of Cardiovascular Diseases Especially Atrial Fibrillation and High Usage Rates of Electrical Ablation in the Treatment of Disease
Competitive Landscape:
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Medtronic PLC (Ireland), Biosense Webster, Inc. (United States), St. Jude Medical, Inc. (United States), Boston Scientific Corporation (United States), Angiodynamics, Inc. (United States), Atricure, Inc. (United States), Conmed Corporation (United States), Olympus Corporation (Japan), Smith & Nephew (United Kingdom) and Galil Medical Inc. (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Ablation Technology market by 2028. Considering Market by Function Type, the sub-segment i.e. Automated/Robotic will boost the Ablation Technology market. Considering Market by End-Use, the sub-segment i.e. Cardiovascular Disease Treatment will boost the Ablation Technology market.
Latest Market Insights:
In August 2022, Medtronic plc, a renowned healthcare technology company, acquired Affera, Inc. This strategic move further enhances Medtronic's cardiac ablation offerings by integrating Affera's cutting-edge cardiac mapping and navigation platform. This comprehensive solution encompasses a unique, fully integrated diagnostic system, as well as focal pulsed field and radiofrequency ablation capabilities. With this acquisition, Medtronic reinforces its position as a leader in the field of cardiac ablation technology.
In October 2022, Biosense Webster, Inc., a division of Johnson & Johnson MedTech, unveiled the HELIOSTAR™ Balloon Ablation Catheter in Europe. This groundbreaking catheter is the first of its kind, utilizing radiofrequency technology for balloon ablation procedures. The HELIOSTAR™ Balloon Ablation Catheter is specifically designed for catheter-based cardiac electrophysiological mapping, which involves stimulating and recording the activities of the atria. Additionally, when used in conjunction with a compatible multi-channel RF generator, it can be employed for cardiac ablation purposes.
What Can be Explored with the Ablation Technology Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Ablation Technology Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Ablation Technology
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Ablation Technology market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Ablation Technology market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Providers of Ablation Technology, End-Users, Potential Investors, Market Research Firms and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.